Alosetron (Compound)

Synonyms:alosetron, 122852-42-0, Lotronex, GR68755, Alosetron (INN), CHEBI:253342, 5-methyl-2-[(5-methyl-1H-imidazol-4-yl)methyl]-3,4-dihydropyrido[4,3-b]indol-1-one, 2,3,4,5-Tetrahydro-5-methyl-2-((5-methyl-1H-imidazol-4-yl)methyl)-1H-pyrido(4,3-b)indol-1-one, 1H-Pyrido(4,3-b)indol-1-one, 2,3,4,5-tetrahydro-5-methyl-2-((5-methyl-1H-imidazol-4-yl)methyl)-, A03AE01, 13Z9HTH115, ALOSETRON [INN], Alosetron [INN:BAN], MLS001401464, 5-methyl-2-[(5-methyl-1H-imidazol-4-yl)methyl]-1H,2H,3H,4H,5H-pyrido[4,3-b]indol-1-one, 5-Methyl-2-[(4-methyl-1H-imidazol-5-yl)methyl]-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indol-1-one, 5-methyl-2-[(5-methyl-1H-imidazol-4-yl)methyl]-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indol-1-one, NCGC00167528-01, SMR000469211, UNII-13Z9HTH115, test_ligand_3, 2,3,4,5-Tetrahydro-5-methyl-2-[(5-methyl-1H-imidazol-4-yl)methyl]-1H-pyrido[4,3-b]indol-1-one, 5-methyl-2-((4-methyl-1H-imidazol-5-yl)methyl)-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indol-1-one, 5-methyl-2-((5-methyl-1h-imidazol-4-yl)methyl)-2,3,4,5-tetrahydro-1h-pyrido[4,3-b]indol-1-one, ALOSETRON [MI], ALOSETRON [VANDF], SCHEMBL631, ALOSETRON [WHO-DD], CHEMBL1110, cid_60758, GTPL2296, DTXSID6044278, BDBM93624, GTPL12214, HMS3745K07, BCP14060, BDBM50014558, HY-70050A, CS-0640, DB00969, AS-83859, FT-0631108, D07129, AB00698548-07, A804977, EN300-18563823, Q416463, Q-200612, 5-Methyl-2-(5-methyl-1H-imidazol-4-ylmethyl)-2,3,4,5-tetrahydro-pyrido[4,3-b]indol-1-one, 2,3,4,5-tetrahydro-5-methyl-2-[(5-methyl-1H-imidazol-4-yl)methyl]-1H-pyrido[4,3-b]indol-1one, 5-Methyl-2-(5-methyl-3H-imidazol-4-ylmethyl)-2,3,4,5-tetrahydro-pyrido[4,3-b]indol-1-one hydrochloride, 5-methyl-2-[(5-methyl-1H-imidazol-4-yl)methyl]-3,4-dihydropyrid[4,3-b]indol-1-one;hydrochloride

Pubchem:PUBCHEM:2099

Id:9bad7039-7f93-5448-9987-4416d1ad738b

Description:nan

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Alosetron's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Alosetron.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Alosetron.

Results found

Linked to

	Label	Description
	BRD-K46742498-003-11-0 Substance (Entity type)	A Substance
	alosetron (19b0ff13-ab2d-4ef6-957c-06249fe1df9f) Collection (Entity type)	Metadatata for alosetron
	DCSTRUCT ID 00129 Collection (Entity type)	DrugPage Collection: (DrugCentralID:00129; PubChem_CID:2099, FILE=drugcentral_drug_00129.json)
	Alosetron positively regulates SPRED2 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Alosetron in similarity relationship with Cefotaxime Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Alosetron indication Irritable bowel syndrome with diarrhea Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Prenylamine in similarity relationship with Alosetron Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Alosetron positively regulates MAGEA6 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Alosetron negatively regulates CRK Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Alosetron negatively regulates CFH Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS